Snam stock edges higher as Bioenerys sale enters final phase

Snam stock is modestly higher as investors focus on the final stage of the planned sale of its biomethane unit Bioenerys, a deal reported to be valued between EUR 400 million and EUR 500 million and expected to close by year-end.

Snam stock (ISIN IT0003153415) is trading slightly higher around a recent closing price of 5.744 EUR as of September 1, 2026, while investors assess reports that the sale of its biomethane subsidiary Bioenerys could reach a value between 400 million EUR and 500 million EUR with a potential closing by the end of 2026.

Bioenerys sale moves into decisive phase

According to an article reported on September 2, 2026, the sale process for Bioenerys, Snam's biomethane unit, has advanced to the final phase, with a shortlist of bidders including infrastructure investor F2i, energy group Edison and Retina Biometano as key candidates to acquire different parts of the business or the entire perimeter. The same report indicates that the overall transaction value could fall in a range of 400 million EUR to 500 million EUR and that the process is expected to move into a decisive phase in September with the goal of completion by year-end, highlighting a potentially meaningful monetization of Snam's biomethane portfolio. For investors, this range provides a concrete frame for assessing how much capital Snam could redeploy into its core regulated gas infrastructure or new energy transition projects.

Additional market commentary on September 2, 2026 notes that Bioenerys is a Snam-controlled company active in biomethane, and that the shortlisted bidders have different strategic interests, with one party reportedly interested in acquiring the full scope of Bioenerys while others focus on specific divisions. This structure suggests that Snam may have flexibility in carving out assets to maximize value, potentially comparing offers for the entire unit versus partial disposals. From a valuation perspective, a midpoint deal value of about 450 million EUR would represent a significant cash inflow relative to Snam's typical annual investment levels in its energy transition businesses.

Recent stock performance on Borsa Italiana

Market data compiled on September 2, 2026 show that Snam's last closing price on Borsa Italiana was 5.744 EUR, with the stock down 0.90 percent on that trading day and reflecting a recent five day performance of negative 2.11 percent and a market capitalization of about 22.35 billion EUR as indicated by the same price snapshot. The price level of 5.744 EUR can be compared against an indicative recent reference level of approximately 5.717 EUR used in the same quote overview, suggesting that the stock has been fluctuating within a narrow band over recent sessions as investors weigh macro factors such as interest rates and energy prices alongside company specific developments like the Bioenerys transaction.

On September 2, 2026, a broader report on the Milan market noted that the energy segment was among the gainers, with Snam cited with a positive intraday move of about 0.59 percent in early trading relative to the previous close. This move, while moderate, stands out in the context of a mixed European session and indicates that news about the progress of asset sales and the resilience of regulated infrastructure earnings can provide some support for Snam shares even when the wider Italian equity market sees varied performance across sectors.

Business profile with biomethane focus

Snam operates one of Europe's largest gas transmission and storage networks and has increasingly expanded into energy transition segments such as biomethane, hydrogen ready infrastructure and renewable gas solutions, with Bioenerys representing a key biomethane platform within its portfolio. The reported potential sale of Bioenerys, if completed around a valuation range of 400 million EUR to 500 million EUR as described by market sources on September 2, 2026, would underline the monetizable value of Snam's development work in this niche and could free up capital for further investments in regulated pipelines, storage or other low carbon initiatives. Historical disclosures from previous fiscal years have highlighted that Snam's energy transition businesses, including biomethane, contributed a growing share of group investments and revenues, even if the bulk of earnings still derives from regulated gas infrastructure.

For long term oriented investors, the Bioenerys process also provides a concrete benchmark for the valuation of similar platforms in Europe, making it easier to compare Snam's strategy with that of other European gas grid operators that are also investing in biomethane and renewable gas. In addition, the emergence of bidders ranging from infrastructure funds to industrial energy players illustrates the strategic attractiveness of biomethane assets, which can provide both environmental benefits and relatively stable contracted cash flows when underpinned by long term off take agreements and supportive regulation.

Representative Snam infrastructure asset

One representative example of Snam's asset base is its high pressure gas transmission network in Italy, which spans thousands of kilometers of pipelines designed to transport natural gas and, increasingly, renewable gases across the country. This network forms the backbone of the Italian gas system and enables the integration of supply from domestic production, imports and emerging biomethane and hydrogen projects. The company has previously communicated that it is investing significant capital expenditures into modernizing and adapting this network to be hydrogen ready and to support the energy transition, while maintaining the reliability demanded by industrial customers and households. These infrastructure investments, combined with targeted asset rotation such as the planned Bioenerys sale, are central to Snam's strategy of balancing regulated returns with growth in innovative low carbon businesses.

Stock price and investor view

As of the most recent completed trading session on September 1, 2026, Snam's last closing price on Borsa Italiana stood at 5.744 EUR, with the stock showing a daily decline of 0.90 percent but supported by a market capitalization of about 22.35 billion EUR and a relatively modest recent five day drawdown of 2.11 percent. For investors, the key question in the coming months will be how the final negotiated value of the Bioenerys sale compares with the indicated range of 400 million EUR to 500 million EUR and how Snam allocates the resulting proceeds across debt reduction, dividends and new investments in its core regulated gas infrastructure and energy transition projects.

Snam stock key data

• Company: Snam S.p.A.
• ISIN: IT0003153415
• Ticker: SRG
• Trading venue: Borsa Italiana
• Price (as of September 1, 2026): 5.744 EUR
• Market capitalization: 22.35 billion EUR (as of September 1, 2026)
• Sector / Industry: Utilities / Gas Utilities
• Index membership: FTSE MIB